Pharmaceutical Research and Manufacturers of America (PhRMA)
Registered Principal Details
Business Or Interest:
Research and manufacturing pharmaceuticals organizations
Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries
CEO Name:
Stephen Ubl
National Vice President
Research and manufacturing pharmaceuticals organizations
Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries
CEO Name:
Stephen Ubl
National Vice President
Contact
KM
Kenneth McKay
950 F Street NW, Suite 300
Washington, DC 20004
(202) 835-3547
kmckay@phrma.org
http://www.phrma.org
950 F Street NW, Suite 300
Washington, DC 20004
(202) 835-3547
kmckay@phrma.org
http://www.phrma.org
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 184
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
For
Notification Date3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 215
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
3/22/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
For
Notification Date3/22/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Agriculture, Trade, and Consumer Protection: Food Safety and Consumer Protection
Agriculture, Trade, and Consumer Protection: Food Safety and Consumer Protection
Notification Date
3/2/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/2/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Biennial budget bill treatment of matter relating to
Health Services: Medicaid Services
Health Services: Medicaid Services
Notification Date
3/2/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/2/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Biennial budget bill treatment of matter relating to
Insurance: Departmentwide
Insurance: Departmentwide
Notification Date
3/2/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/2/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
co-pay accumulator
co-pay accumulator
Action Intended To Affect
Both Legislative matter and rule
Notification Date
2/11/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
2/11/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
access to prescription medications
access to prescription medications
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/8/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
1/8/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Governor's Rx Task Force
Governor's Rx Task Force
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
COVID-19 Executive and other orders
COVID-19 Executive and other orders
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2021 January - June $38,286.50 |
2021 July - December $36,620.88 |
2022 January - June $38,164.37 |
2022 July - December $34,414.37 |
Total $147,486.12 |
| Total Hours Communicating | 2021 January - June 18.50 |
2021 July - December 27.50 |
2022 January - June 9.50 |
2022 July - December 1.00 |
Total 56.50 |
| Total Hours Other | 2021 January - June 51.00 |
2021 July - December 33.00 |
2022 January - June 21.50 |
2022 July - December 29.50 |
Total 135.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 10% |
2021 July - December 35% |
2022 January - June 28% |
2022 July - December |
Total 19% |
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 10% |
2021 July - December 35% |
2022 January - June 28% |
2022 July - December |
Total 19% |
Budget Bill Subjects
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 5% |
2021 July - December |
2022 January - June |
2022 July - December |
Total 2% |
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 5% |
2021 July - December |
2022 January - June |
2022 July - December |
Total 2% |
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June 12% |
2022 July - December |
Total 2% |
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December 5% |
2022 January - June 2% |
2022 July - December 24% |
Total 6% |
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December 10% |
2022 January - June |
2022 July - December 24% |
Total 7% |
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December 9% |
Total 1% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication